Prostate Cancer
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
November 7, 2023
Personalized Medicine for Metastatic Prostate Cancer: The Paradigm of PARP Inhibitors.
November 7, 2023
New Radiopharmaceutical Shows Antitumor Activity in Patients with Advanced Prostate Cancer
November 6, 2023
Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population.
November 6, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers.
November 6, 2023
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
November 6, 2023
Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.
November 6, 2023
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis.
November 3, 2023
Statin use and outcomes of oncological treatment for castration-resistant prostate cancer.
November 3, 2023
Preclinical evaluation of [58mCo]Co-DOTA-PSMA-617 for Auger electron therapy of prostate cancer.
November 3, 2023